Lorna Hopcroft
6PUBLICATIONS
47CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 15, 2026
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancer.Valentina Cutano, Shanade Dunn, Sungmi Park-Chouinard
|Apr 22, 2025
The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer.Valentina Cutano, Ming Li Chia, Eleanor M Wigmore
|May 13, 2024
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC.Thomas G Hayhow, Beth Williamson, Mandy Lawson
|Sep 19, 2023
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.Lorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson
|Aug 18, 2023
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.Lorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson
|Aug 05, 2023
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.Lorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson
Pageof 1
Frequent Collaborators
5 joint publications
Susana Ros
5 joint publications
Simon T Barry
4 joint publications
Stuart C Williamson
4 joint publications
Elza DeBruin
3 joint publications
Larissa S Carnevalli
2 joint publications
Cath Eberlein
2 joint publications
Eleanor M Wigmore
2 joint publications
Valentina Cutano
1 joint publications
Thomas G Hayhow
1 joint publications
David I Fisher
